Beruflich Dokumente
Kultur Dokumente
O R I G I N A L A R T I C L E
T
ests of glycemia and their thresholds to diabetes, and it represents a specific
for diabetes diagnosis is an area of and relevant clinical end point for judging thy in the U.S. population and to compare
long-standing debate. The presence an alternative test (1). For these reasons, the ability of both measures to differentiate
of diabetic retinopathy is arguably the diabetic retinopathy has served as the ba- people with and without retinopathy.
best criterion from which to compare gly- sis for diagnostic criteria of type 2 diabe-
cemic measures because it is a specific and tes (2 4) and provides the rationale for
early clinical complication usually related the American Diabetes Associations rec- RESEARCH DESIGN AND
METHODS We analyzed 20052006
data from NHANES, a cross-sectional na-
From the 1Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health tionally representative sample of the U.S.
Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; the 2National Institute of
Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland; and the 3Department of Ophthalmology civilian noninstitutionalized population.
and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. The sample was obtained using a strati-
Corresponding author: Yiling J. Cheng, ycheng@cdc.gov. fied multistage probability design with
Received 6 March 2009 and accepted 13 June 2009. planned oversampling of older people
The findings and conclusions in this report are those of the authors and do not necessarily represent the
official position of the Centers for Disease Control and Prevention, the National Institute of Diabetes and
and minority groups. Detailed descrip-
Digestive and Kidney Diseases, or the University of Wisconsin School of Medicine and Public Health. tions of the design and data collection of
DOI: 10.2337/dc09-0440 the survey are published on the National
2009 by the American Diabetes Association. Readers may use this article as long as the work is properly Center for Health Statistics website (10).
cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons. A total of 3,056 people aged 40 years and
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
older were interviewed, and their socio-
marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. demographic, medical, and family infor-
See accompanying editorial, p. 2140. mation were obtained. Of those who
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 2027
Association of A1C and glucose on retinopathy
attended the mobile examination center, Table 1Characteristics of analytic population by diabetic retinopathy status
1,393 people (46%) were randomized to
a morning session where blood was No
drawn for the measurement of FPG and retinopathy Retinopathy P
A1C and retinal fundus photography ex-
aminations were performed. After exclud- n 913 153
ing people who fasted 8 or 24 h (n Age (years) 55.9 0.61 60.3 1.83 0.024
144), pregnant women (n 2), those Men (%) 46.7 1.61 56.0 3.97 0.010
with invalid FPG (n 24) or A1C values Race/ethnicity (%) 0.048
(n 4), and those without completed ret- Non-Hispanic white 79.8 2.55 70.1 5.21
inopathy grading (n 153), the final an- Non-Hispanic black 8.3 1.46 15.4 4.14
alytic sample consisted of 1,066 adults. Other 11.9 1.82 14.6 4.91
For the latter exclusion, fundus photog- FPG (mmol/l) 5.8 0.07 6.9 0.24 0.001
raphy was not completed for individuals A1C (%) 5.6 0.02 6.4 0.12 0.001
because of lack of time available to com- Diabetes (%) 7.8 0.92 35.6 3.40 0.001
plete the examination (n 64), physical Diabetes treatment (%) 6.4 0.81 34.0 3.16 0.001
limitations (n 25), eye-specific limita- Hypertension (%) 42.1 2.26 60.1 6.49 0.009
tions (n 16), refusal (n 19), commu- Data are means SE.
nication problems (n 5), accompanying
child (n 5), illness (n 4), and equip-
ment failure or unspecified problems white, non-Hispanic black, others) were prevalence of A1C or FPG level below the
(n 15). The NHANES protocol was ap- self-reported. joinpoint and a linear association above.
proved by a human subjects review In addition, to summarize and compare
board, and informed consent was ob- Statistical analysis the ability of A1C and FPG to identify ret-
tained from all participants. We compared three approaches to cate- inopathy cases, we used Stata (version
Two 45 nonmydriatic color digital gorizing A1C and FPG. First, we used de- 10.1; StataCorp, College Station, TX) and
images of the retina were taken of each eye ciles, a widely used approach, to group applied logistic regression, accounting for
by a technologist using a Canon CR6- data. Second, we applied the cut points the complex survey design, to calculate
45NM ophthalmic digital imaging system used in an analysis of the Pima Indians the predicted probability of retinopathy
and Canon EOS 10D digital camera. The (2). Third, since both approaches may not for each participant and the areas under
first image was centered on the macula, yield a precise change point, we also used receiver operating characteristic curves
and the second was centered on the optic a moving average smoothing technique. (AUCs). Larger values of AUC indicate a
nerve. Retinopathy lesions were graded at Taking a 0.1-unit increment each time better ability to discriminate. Because there
the University of Wisconsin Ocular Epi- from the lowest to the highest levels of A1C is no postestimation command of AUC cal-
demiology Reading Center according to and FPG, we created a series of subsets culation specifically for complex sampling
the modified Airlie House classification with a 0.5-unit range of A1C or FPG (win- of survey data, the variation of AUC in this
system, as used in the Early Treatment dow) and then calculated the mean A1C study might be underestimated.
Diabetic Retinopathy Study (ETDRS) and FPG and the prevalence of retinopa- Our primary analyses included peo-
(11). Participants were dichotomized thy for each subset. SAS callable SUDAAN ple with and without diabetes. Because of
based on ETDRS severity level as having (version 9.0.1; SUDAAN Statistical Soft- the potential for confounding from hypo-
retinopathy (14) or not having retinop- ware Center, Research Triangle Park, NC) glycemic treatment, we conducted sensi-
athy (14). was used to calculate standard errors tivity analyses in which we excluded
A1C was measured by high-perfor- based on Taylor Series linearization. participants receiving hypoglycemic
mance liquid chromatography (HPLC), as Joinpoint regression, in which the re- medications. This exclusion eliminated
used in the Diabetes Control and Compli- lationship between the dependent and 34% of those with retinopathy.
cations Trial (10). FPG was measured in independent variables is modeled as
the morning after an 8- to 24-h fast at a piecewise linear phases, is often useful to
central laboratory using a hexokinase en- describe changes in trend data. It is also RESULTS The overall study popu-
zymatic method (10). called piecewise regression, segmented lation, weighted to be representative of
Participants were asked if a doctor or regression, broken line regression, or the U.S. noninstitutionalized population
health care professional had ever told multiphase regression with the continu- aged 40 years, had a mean age of 56
them they have diabetes (other than ges- ity constraint (12). We used logistic re- years, 47% were male, 79% were non-
tational diabetes). Those who responded gression, accounting for the complex Hispanic white, 9% were non-Hispanic
yes were classified as having diagnosed sampling design, to obtain predicted black, and 12% were of other race and
diabetes. prevalences and standard errors; we then ethnicity. Mean A1C and FPG were 5.7%
Hypertension was defined as use of tested the null hypothesis of no change and 5.9 mmol/l (106 mg/dl), respectively.
antihypertensive medication or the mean points of these prevalences by glucose cat- Among the participants with diabetes,
of three or four readings of systolic blood egories using joinpoint regression soft- 88% were using hypoglycemic medica-
pressure 140 mmHg and/or diastolic ware developed by the Surveillance, tion and 40% of those taking hypoglyce-
blood pressure 90 mmHg. Time since Epidemiology, and End Results program mic medication had FPG 7.0 mmol/l. In
diagnosis of diabetes, diabetes treatment, of the National Cancer Institute (version this study population, the prevalence of
age, sex, and race/ethnicity (non-Hispanic 3.3; Rockville, MD). We tested a constant any retinopathy was 11% and was appre-
2028 DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 care.diabetesjournals.org
Cheng and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 2029
Association of A1C and glucose on retinopathy
2030 DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 care.diabetesjournals.org
Cheng and Associates
tion at high risk for developing diabetes people with diabetes, including less inter- newly diagnosed type 2 diabetic subjects.
and found that 8% of people with FPG ference by hemoglobinopathies, more re- Diabetes Care 1999;22:394 398
below diabetic levels had retinopathy liability, and no need for validation by the 9. Sacks DB, Bruns DE, Goldstein DE, Ma-
(21). Similar findings have been reported complicated mass spectrometry method. claren NK, McDonald JM, Parrott M.
Guidelines and recommendations for lab-
by others (5). In our study, 8% of partic- In summary, based on the latest na-
oratory analysis in the diagnosis and man-
ipants with FPG 7.0 mmol/l had reti- tionally representative sample, our analy- agement of diabetes mellitus. Clin Chem
nopathy. Longitudinal studies have sis examined the association of A1C with 2002;48:436 472
reported that the presence of retinopathy retinopathy and provides new informa- 10. National Center for Health Statistics:
in people with normal glucose levels at tion on defining cut points for diagnosing NHANES 20052006 Manuals, Bro-
baseline predicts the development of dia- diabetes. While the A1C and FPG levels of chures, Consent Documents [Internet].
betes (22,23), suggesting that some fac- 5.5% and 5.8 mmol/l provide start points Centers for Disease Control and Preven-
tors may play a role in the pathogenesis of at which retinopathy prevalence increases tion. Available at http://www.cdc.gov/nchs/
both microvascular changes and diabetes. most precipitously, A1C appears to dis- about/major/nhanes/nhanes20052006/
The presence of retinopathy among non- criminate between the presence and ab- current_nhanes_05_06.htm. Accessed 15
diabetic individuals may also be related to sence of retinopathy at least as well as FPG May 2009
11. Diabetic Retinopathy Study Research
other conditions such as hypertension. In and offers some advantages over FPG. Group. Diabetic retinopathy study: Re-
our subset analysis among people without port number 6: design, methods, and
diabetes, the prevalence of retinopathy baseline results; Report number 7: a mod-
was 10% in those with hypertension and Acknowledgments No potential conflicts of ification of the Airlie House classification
6% in those without hypertension (P interest relevant to this article were reported. of diabetic retinopathy. Invest Ophthal-
0.222). The presence of these retinal le- mol Vis Sci 1981;21:1226
sions in nondiabetic people is likely to 12. Kim HJ, Fay MP, Feuer EJ, Midthune DN.
attenuate the detection of the change References Permutation tests for joinpoint regression
point of glucose level for retinopathy. Ex- 1. McCance DR, Hanson RL, Pettitt DJ, Ben- with applications to cancer rates. Stat Med
amining the prevalence of more advanced nett PH, Hadden DR, Knowler WC. Diag- 2000;19:335351
nosing diabetes mellitus: do we need new 13. Miyazaki M, Kubo M, Kiyohara Y, Okubo
retinopathy by A1C levels may help in K, Nakamura H, Fujisawa K, Hata Y, To-
criteria? Diabetologia 1997;40:247255
the identification of diagnostic cut 2. McCance DR, Hanson RL, Charles MA, kunaga S, Iida M, Nose Y, Ishibashi T,
points. However, because only 2 years of Jacobsson LT, Pettitt DJ, Bennett PH, Hisayama study. Comparison of diagnos-
NHANES data are available, there is insuf- Knowler WC. Comparison of tests for gly- tic methods for diabetes mellitus based on
ficient power to explore this issue further. cated haemoglobin and fasting and two prevalence of retinopathy in a Japanese
Second, our main analyses included hour plasma glucose concentrations as di- population: the Hisayama Study. Diabe-
people with previous hypoglycemic treat- agnostic methods for diabetes. BMJ 1994; tologia 2004;47:14111415
ment. The inclusion of people on such 308:13231328 14. Davidson MB, Schriger DL, Peters AL,
treatment could artificially reduce levels 3. Engelgau MM, Thompson TJ, Herman Lorber B. Relationship between fasting
of glycemia in the population and lead to WH, Boyle JP, Aubert RE, Kenny SJ, Bad- plasma glucose and glycosylated hemoglo-
ran A, Sous ES, Ali MA. Comparison of bin: potential for false-positive diagnoses of
an overestimation of the steepness in the
fasting and 2-hour glucose and HbA1c type 2 diabetes using new diagnostic crite-
prevalence of retinopathy by glycemic levels for diagnosing diabetes. Diagnostic ria. JAMA 1999;281:12031210
level. Theoretically, a preferable study de- criteria and performance revisited. Diabe- 15. Holmes EW, Ersahin C, Augustine GJ,
sign would follow people without diabe- tes Care 1997;20:785791 Charnogursky GA, Gryzbac M, Murrell
tes treatment prospectively until the 4. Expert Committee on the Diagnosis and JV, McKenna KM, Nabhan F, Kahn SE.
development of retinopathy; however, Classification of Diabetes Mellitus: Report Analytic bias among certified methods for
such a design is impractical due to the of the Expert Committee on the Diagnosis the measurement of hemoglobin A1c: a
ethical problem of following high-risk and Classification of Diabetes Mellitus. cause for concern? Am J Clin Pathol 2008;
people without starting hypoglycemic Diabetes Care 2003;26(Suppl. 1):S5S20 129:540 547
treatment. In a sensitivity analysis, we ex- 5. Wong TY, Liew G, Tapp RJ, Schmidt MI, 16. Wong TY, Klein R, Islam FM, Cotch MF,
cluded participants taking diabetes- Wang JJ, Mitchell P, Klein R, Klein BE, Zim- Folsom AR, Klein BE, Sharrett AR, Shea S.
met P, Shaw J. Relation between fasting glu- Diabetic retinopathy in a multi-ethnic co-
related medications. This had no effect on cose and retinopathy for diagnosis of hort in the United States. Am J Ophthal-
the A1C change point but raised the diabetes: three population-based cross-sec- mol 2006;141:446 455
change point for FPG. tional studies. Lancet 2008;371:736 743 17. Saudek CD, Derr RL, Kalyani RR. Assess-
Third, variability among different as- 6. Buell C, Kermah D, Davidson MB. Utility ing glycemia in diabetes using self-moni-
say methods of A1C is a potential source of A1C for diabetes screening in the toring blood glucose and hemoglobin
of inaccuracy whenever A1C results are 1999 2004 NHANES population. Diabe- A1c. JAMA 2006;295:1688 1697
interpreted relative to universal, fixed, tes Care 2007;30:22332235 18. Herman WH, Ma Y, Uwaifo G, Haffner S,
clinical decision thresholds (15). The 7. Petersen PH, Jrgensen LG, Brandslund I, Kahn SE, Horton ES, Lachin JM, Montez
mean and range of percent A1C and per- De Fine Olivarius N, Stahl M. Conse- MG, Brenneman T, Barrett-Connor E, Di-
cent of total glycated hemoglobin mea- quences of bias and imprecision in mea- abetes Prevention Program Research
surements of glucose and hba1c for the Group. Differences in A1C by race and
sured by the ion-exchange method diagnosis and prognosis of diabetes mel- ethnicity among patients with impaired
(which this study used) and the affinity litus. Scand J Clin Lab Invest Suppl 2005; glucose tolerance in the Diabetes Preven-
method are similar. Nevertheless, Nuttall 240:51 60 tion Program. Diabetes Care 2007;30:
(24,25) argued that affinity chromatogra- 8. Ollerton RL, Playle R, Ahmed K, Dunstan 24532457
phy has significant advantages over the FD, Luzio SD, Owens DR. Day-to-day 19. Cohen RM, Snieder H, Lindsell CJ, Beyan
ion-exchange HPLC, especially among variability of fasting plasma glucose in H, Hawa MI, Blinko S, Edwards R, Spec-
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 2031
Association of A1C and glucose on retinopathy
tor TD, Leslie RD. Evidence for indepen- onset diabetes in the Diabetes Preven- relationship of retinopathy in persons
dent heritability of the glycation gap tion Program. Diabet Med 2007;24:137- without diabetes to the 15-year incidence
(glycosylation gap) fraction of HbA1c in 144 of diabetes and hypertension: Beaver Dam
nondiabetic twins. Diabetes Care 2006; 22. Tapp RJ, Tikellis G, Wong TY, Harper CA, Eye Study. Trans Am Ophthalmol Soc
29:1739 1743 Zimmet PZ, Shaw JE, Australian Diabetes 2006;104:98 107
20. Cohen RM, Smith EP. Frequency of Obesity and Lifestyle Study Group. Lon- 24. Nuttall FQ. Comparison of percent total
HbA1c discordance in estimating blood gitudinal association of glucose metabo- GHb with percent HbA1c in people with
glucose control. Curr Opin Clin Nutr lism with retinopathy: results from the and without known diabetes. Diabetes
Metab Care 2008;11:512517 Australian Diabetes Obesity and Lifestyle Care 1998;21:14751480
21. Diabetes Prevention Program Research (AusDiab) study. Diabetes Care 2008;31: 25. Nuttall FQ. Total glycohemoglobin or he-
Group. The prevalence of retinopathy in 1349 1354 moglobin A1C? Endocr Pract 2007;13:
impaired glucose tolerance and recent- 23. Klein R, Klein BE, Moss SE, Wong TY. The 317318
2032 DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 care.diabetesjournals.org